Heparin-Induced Thrombocytopenia in Intensive Care PatientsSELLENG, Kathleen; SELLENG, Sixten; GREINACHER, Andreas et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, Num 5, pp 425-438, issn 0094-6176, 14 p.Article

Cutaneous dalteparin reactions associated with antibodies of heparin-induced thrombocytopeniaPAYNE, Sonja M; KOVACS, Michael J.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 655-658, issn 1060-0280, 4 p.Article

Argatroban dosing in patients with heparin-induced thrombocytopeniaVERME-GIBBONEY, Catherine N; HURSTING, Marcie J.The Annals of pharmacotherapy. 2003, Vol 37, Num 7-8, pp 970-975, issn 1060-0280, 6 p.Conference Paper

Excessive argatroban anticoagulation for heparin-induced thrombocytopeniaREICHERT, Marc G; MACGREGOR, Drew A; KINCAID, Edward H et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 5, pp 652-654, issn 1060-0280, 3 p.Article

Platelet receptor and clotting factor polymorphisms as genetic risk factors for thromboembolic complications in heparin-induced thrombocytopeniaCARLSSON, Lena E; LUBENOW, Norbert; BLUMENTRITT, Carmen et al.Pharmacogenetics (London). 2003, Vol 13, Num 5, pp 253-258, issn 0960-314X, 6 p.Article

Heparin-induced thrombocytopenia : What clinicians need to knowCHONG, Beng H; ISAACS, Arend.Thrombosis and haemostasis. 2009, Vol 101, Num 2, pp 279-283, issn 0340-6245, 5 p.Article

Heparin-induced thrombocytopenia in children: 12 new cases and review of the literatureKLENNER, Anne F; LUBENOW, Norbert; RASCHKE, Ricarda et al.Thrombosis and haemostasis. 2004, Vol 91, Num 4, pp 719-724, issn 0340-6245, 6 p.Article

Clinical Experience of Argatroban in GermanyDEMPFLE, Carl-Erik.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 48-51, issn 0094-6176, 4 p., SUP1Article

Heparin-induced thrombocytopenia : A reviewGIROLAMI, Bruno; GIROLAMI, Antonio.Seminars in thrombosis and hemostasis. 2006, Vol 32, Num 8, pp 803-809, issn 0094-6176, 7 p.Article

Heparin-induced thrombocytopenia (HIT) : A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004MAGNANI, Harry N; GALLUS, Alex.Thrombosis and haemostasis. 2006, Vol 95, Num 6, pp 967-981, issn 0340-6245, 15 p.Article

Heparin-induced thrombocytopenia and recent advances in its therapyHASSAN, Y; AWAISU, A; AZIZ, N. A et al.Journal of clinical pharmacy and therapeutics (Print). 2007, Vol 32, Num 6, pp 535-544, issn 0269-4727, 10 p.Article

The management of heparin-induced thrombocytopeniaKEELING, David; DAVIDSON, Simon; WATSON, Henry et al.British journal of haematology. 2006, Vol 133, Num 3, pp 259-269, issn 0007-1048, 11 p.Article

Update on heparin-induced thrombocytopenia and cardiovascular interventionsSPIESS, Bruce D.Seminars in hematology. 2005, Vol 42, Num 3, pp S22-S27, issn 0037-1963, SUP3Conference Paper

What is the potential for overdiagnosis of heparin-induced thrombocytopenia?LO, Gregory K; SIGOUIN, Christopher S; WARKENTIN, Theodore E et al.American journal of hematology. 2007, Vol 82, Num 12, pp 1037-1043, issn 0361-8609, 7 p.Article

Heparin-induced thrombocytopeniaAREPALLY, Gowthami M; ORTEL, Thomas L.The New England journal of medicine. 2006, Vol 355, Num 8, pp 809-817, issn 0028-4793, 9 p.Article

Current developments in antithrombotic therapy: The role of antithrombin agentsBREDDIN, H. K.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 1-8, issn 1424-8832, 8 p., SUP3Conference Paper

Rivaroxaban : an oral, direct Factor Xa inhibitor -has potential for the management of patients with heparin-induced thrombocytopeniaWALENGA, Jeanine M; PRECHEL, Margaret; JESKE, Walter P et al.British journal of haematology. 2008, Vol 143, Num 1, pp 92-99, issn 0007-1048, 8 p.Article

Platelet PI^A2 Polymorphism and the Risk for Thrombosis in Heparin-lnduced ThrombocytopeniaHARRIS, Kenneth; NGUYEN, Phan; VAN COTT, Elizabeth M et al.American journal of clinical pathology. 2008, Vol 129, Num 2, pp 282-286, issn 0002-9173, 5 p.Article

Mechanisms Involved in Heparin-Induced Thrombocytopenia and Associated ThrombosisVISSAC, Anne Marie; AMIRAL, Jean.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 18-26, issn 0094-6176, 9 p., SUP1Article

Heparin-Induced Thrombocytopenia Clinical Studies and the Efficacy of Argatroban in JapanMIYATA, Shigeki; YAMAMOTO, Haruko; KAMEI, Masataka et al.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 37-47, issn 0094-6176, 11 p., SUP1Article

Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodiesKRAKOW, Elizabeth F; GOUDAR, Ranjit; PETZOLD, Elizabeth et al.American journal of clinical pathology. 2007, Vol 128, Num 1, pp 150-155, issn 0002-9173, 6 p.Article

Hemodialysis and ArgatrobanMATSUO, Takefumi; WANAKA, Keiko.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 56-61, issn 0094-6176, 6 p., SUP1Article

Pseudo-pulmonary embolism as a sign of acute heparin-induced thrombocytopenia in hemodialysis patients : Safety of resuming heparin after disappearance of HIT antibodies. CommentaryHARTMAN, V; MALBRAIN, M; DAELEMANS, R et al.The Nephron journals. 2006, Vol 104, Num 4, issn 1660-8151, c143-c150Article

Laboratory testing for heparin-induced thrombocytopenia is inconsistent in North America : A survey of North American specialized coagulation laboratoriesPRICE, Elizabeth A; HAYWARD, Catherine P. M; MOFFAT, Karen A et al.Thrombosis and haemostasis. 2007, Vol 98, Num 6, pp 1357-1361, issn 0340-6245, 5 p.Article

Heparin-induced thrombocytopenia (HIT) : Clinical and economic outcomesBAROLETTI, Steven; PIOVELLA, Chiara; FANIKOS, John et al.Thrombosis and haemostasis. 2008, Vol 100, Num 6, pp 1130-1135, issn 0340-6245, 6 p.Article